The Pharmaco vigilance Committee for P K Das Institute of Medical Sciences which is running under the guidelines.

Pharmaco Vigilance Committee

Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Program for International Drug Monitoring in response to the thalidomide disaster detected in 1961. At the end of 2010, 134 countries were part of the WHO PV Program, India being one of them. PK Das Institute of Medical Sciences aims to enhance patient care and patient safety in relation to the use of medicines; and to support public health programs by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.


Objectives of the Pharmacovigilance committee in PK Das Institute of Medical Sciences.

Pharmaco Vigilance Committee

PKDIMS’s Pharmaco Vigilance Committee for the year 2022-23.

Click to view